Abstract:Objective: Mesenchymal subtype of glioblastoma (mesGBM) is a refractory disease condition characterized by therapeutic failure and tumor recurrence. Hyperactive transforming growth factor-beta (TGF-beta) signaling could be a signature event in mesGBM, which leads to dysregidation of downstream targets and contribute to malignant transformation. In this study we aimed to investigate the hyperactive TGF beta signalling mediated pathogenesis and possible downstream targets for the development of novel therapeutic interventions for mesGBM. Methods: GBM-BioDP is an online resource for accessing and displaying interactive views of the TCGA GBM data set. Transcriptomic sequencing followed by bioinformatic analysis was performed to identify dysregulated microRNAs. Target prediction by MR-microT and dual luciferase reporter assay were utilized to confirm the predicted target of novel_miR56. CCK-8 assays was used to assesse cell viability. The miRNA manipulation was proceeded by cell transfection and lentivirus delivery. A plasmid expressing GFP-LC3 was introduced to visualize the formation of autophagosomes. Orthotopic GBM model was constructed for in vivo study. Results: TGF beta 1 and TGF beta receptor type II (T beta RII) were exclusively upregulated in mesGBM (P < 0.01). Dysregulated miRNAs were identified after LY2109761 (a T beta RI/II inhibitor) treatment in a mesGBM-derived cell line, and novel_miR56 was selected as a promising candidate for further functional verification. Novel_miR56 was found to potentially bind to PRAS40 via seed region complementarity in the 3' untranslated region, and we also confirmed that PRAS40 is a direct target of novel_miR56 in glioma cells. In vitro, over expression of novel miR56 in tumor cells significantly promoted proliferation and inhibited autophagy (P < 0.05). The expression levels of P62/SQSTM was significantly increased accompanied by the decrease of BECN1 and LC3B-II/I, which indicated that autophagic activity was reduced after novel_miR56 treatment. In addition, over expression of novel_miR56 also promoted tumor growth and inhibited autophagy in vivo, which is associated with worse prognosis (P < 0.05). Conclusions: In summary, we provide novel insight into TGF beta signaling-mediated pathogenesis in mesGBM and TGF beta signaling-induced novel_miR56 may be a novel target for mesGBM management.

AEG-1/MTDH-activated Autophagy Enhances Human Malignant Glioma Susceptibility to TGF-β1-triggered Epithelial-Mesenchymal Transition

AEG-1 silencing attenuates M2-polarization of glioma-associated microglia/macrophages and sensitizes glioma cells to temozolomide

Data from Astrocyte Elevated Gene-1 Upregulates Matrix Metalloproteinase-9 and Induces Human Glioma Invasion

TMBIM1 Promotes EMT by Stimulating Autophagic Degradation of E-cadherin Via AMPK/mTOR/ULK1 Axis in Human Gliomas

Astrocyte elevated gene-1(AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/β-catenin signaling

Astrocyte elevated gene 1: biological functions and molecular mechanism in cancer and beyond

Progress in Treatment for Malignant Tumors with Astrocyte Elevated Gene-1

Astrocyte elevated gene-1 serves as a target of miR542 to promote glioblastoma proliferation and invasion

Astrocyte Elevated Gene 1 Interacts with Acetyltransferase P300 and C-Jun to Promote Tumor Aggressiveness

HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma

Tumor-Associated Microglia/Macrophages Enhance the Invasion of Glioma Stem-like Cells Via TGF-β1 Signaling Pathway

AEG-1 Overexpression is Essential for Maintenance of Malignant State in Human AML Cells Via Up-Regulation of Akt1 Mediated by AURKA Activation.

High expression of immunity-related GTPase family M protein in glioma promotes cell proliferation and autophagy protein expression

Epidermal Growth Factor (Egf)-Enhanced Vascular Cell Adhesion Molecule-1 (Vcam-1) Expression Promotes Macrophage and Glioblastoma Cell Interaction and Tumor Cell Invasion

Autophagy Suppresses Self-Renewal Ability and Tumorigenicity of Glioma-Initiating Cells and Promotes Notch1 Degradation

TGF signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma

SAE1 Promotes Human Glioma Progression Through Activating AKT SUMOylation-mediated Signaling Pathways

Malignant Gliomas Induce and Exploit Astrocytic Mesenchymal-Like Transition by Activating Canonical Wnt/β-catenin Signaling

ERK inhibition in glioblastoma is associated with autophagy activation and tumorigenesis suppression

Influence of Autophagy on Epithelial-Mesenchymal Transition and Invasion of Glioma Cells

AEG-1 Knockdown Sensitizes Glioma Cells to Radiation Through Impairing Homologous Recombination Via Targeting RFC5